Clinical manifestations and treatment of rheumatoid pachymeningitis.
Starosta
Monika A
MA
Department of Medicine, Lutheran General Hospital, Park Ridge, IL 60068, USA.
Brandwein
Sydney R
SR
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications*; D001921:Brain / Q000473:pathology; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008578:Meninges / Q000276:immunology* / Q000473:pathology*; D008581:Meningitis / Q000276:immunology* / Q000503:physiopathology* / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D015423:Scleritis / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents; D011241:Prednisone; D008727:Methotrexate